CK LIFE SCIENCES INT'L., (HOLDINGS) INC.

Autres langues CK Life Sciences Int'l., (Holdings) Inc.

Actions

775 KYG2176J1058

Marché Fermé - Hong Kong S.E. Autres places de cotation 10:08:06 30/04/2024			Varia. 5j.	Varia. 1 janv.
0,375 ^HKD	+2,74 %		+10,29 %	-39,52 %

05/04	CK Life Sciences présentera les données précliniques de deux vaccins contre le cancer ; les actions augmentent de 11 %.	MT
19/03	CK Life Sciences Int'l., (Holdings) Inc. publie ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

CK Life Sciences to Present Pre-Clinical Data for Two Cancer Vaccines; Shares Up 11%	05/04
CK Life Sciences Int'l., Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	19/03
XtalPi and CK Life Sciences Ink Agreement to Develop Cancer Molecular Diagnostic Models Using AI and Biomarker Data	06/11
CK Life Sciences to Present Preclinical Study of Cancer Vaccines at US Immunotherapy Conference	01/11
Ck Life Sciences Int'l., Inc. Announces Preclinical Data for Its Investigational Dual-Antigen Cancer Vaccines, Co-Targeting Prame and PD-L1	01/11
CK Life Sciences International's Profit Slumps 43% in H1; Shares Down 3%	16/08/23
CK Life Sciences Int'l., Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	01/08/23
CK Life Sciences Int'l., Inc. Announces Ordinary Final Dividend for the Year Ended 31 December 2022, Payment Date 05 June 2023	14/03/23
CK Life Sciences Int'l., Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	14/03/23
XtalPi and CK Life Sciences to collaborate in AI-empowered tumour vaccine research and development opening a new paradigm for scientific innovation	28/11/22
XtalPi Inc. and CK Life Sciences to Collaborate in Ai-Empowered Tumour Vaccine Research and Development, Opening A New Paradigm for Scientific Innovation	25/11/22
CK Life Sciences Int'l., Inc. Announces Retirement of Independent Non-Executive Director and Change in Composition of the Remuneration Committee	01/09/22
CK Life Sciences' H1 Profit Down 35%	03/08/22
CK Life Sciences Int'l., Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	02/08/22
CK Life Sciences Investors Acquire Stake in Pharus for $5.5 Million Each	26/07/22
CK Life Sciences Int'l., Inc. Announces Ordinary Final Cash Dividend for the Year Ended 31 December 2021, Payable on 01 June 2022	15/03/22
CK Life Sciences Int'l., Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	15/03/22
CK Life Sciences Int'l., Inc. acquired Gale Road vineyard.	15/03/22
CK Hutchison : CK Asset profits rise in H1	05/08/21
CK Life Sciences 'l : Posts Higher Profit, Revenue in H1	04/08/21

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues CK Life Sciences Int'l., (Holdings) Inc.

Actions

775

KYG2176J1058

Autres langues

Filtres